Aridis Pharmaceuticals | 4:持股变动声明-董事 Windham-Bannister Susan Richards
Aridis Pharmaceuticals | 4:持股变动声明-董事 HAMILTON JOHN F
Aridis Pharmaceuticals | 4:持股变动声明-高管 Jafri Hasan
Aridis Pharmaceuticals | 4:持股变动声明-董事 Patzer Eric
Aridis Pharmaceuticals | 4:持股变动声明-高管 Truong Vu
Aridis Pharmaceuticals | 8-K:重大事件
Aridis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Aridis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%)等
Aridis Pharmaceuticals | 8-K:重大事件
Aridis Pharmaceuticals | DEFA14A:其他
Aridis Pharmaceuticals | 8-K:重大事件
Aridis Pharmaceuticals | DEFA14A:其他
Aridis Pharmaceuticals | 10-Q:2023财年三季报
Aridis Pharmaceuticals | 8-K:Aridis Pharmicals公布2023年第三季度财务业绩和业务最新情况
Aridis Pharmaceuticals | DEFA14A:其他
Aridis Pharmaceuticals | ARS:年度报告
Aridis Pharmaceuticals | DEF 14A:股东委托书决议
Aridis Pharmaceuticals | 4:持股变动声明-董事 HAMILTON JOHN F
Aridis Pharmaceuticals | 4:持股变动声明-董事 Windham-Bannister Susan Richards
Aridis Pharmaceuticals | 4:持股变动声明-董事会执行主席 Patzer Eric
暂无数据